ECO Animal Health Group

1. 17 Sep 26
   USDA-CVB approves ECOVAXXIN® MS field safety data

   Milestone advances poultry vaccine towards US marketing authorisation

   RNS 9776307 ↗
2. 11 Sep 26
   Share Awards to Executive Directors

   ECO Animal Health Group plc (AIM: EAH), a leading global animal health company developing and marketing branded veterinary products to improve livestock productivity and welfare, announces that on 9 September 2026, nominal cost conditional share options...

   RNS 9767728 ↗
3. 08 Sep 26
   Didier Branellec appointed Non-Executive Director

   ECO Animal Health Group plc (AIM: EAH), a leading global animal health company developing and marketing branded veterinary products to improve livestock productivity and welfare, announces the appointment of Dr.

   RNS 9759861 ↗
4. 19 Aug 26
   CEO and CFO Exercise of Options and RPT

   CEO and CFO Exercise of Share Options and Director/PDMR Shareholdings

   RNS 9730635 ↗
5. 12 Aug 26
   Exclusive in-licensing agreement with Vaxinano

   Exclusive in-licensing agreement with Vaxinano for sheep vaccine candidate against toxoplasmosis

   RNS 9716721 ↗
6. 16 Jul 26
   Director/PDMR Shareholding: CEO Share Purchase Director buys

   ECO Animal Health Group plc (AIM: EAH), a leading global animal health company developing and marketing branded veterinary products to improve livestock productivity and welfare, announces that on 16 July 2026 David Hallas, Chief Executive Officer,...

   RNS 9673131 ↗
7. 15 Jul 26
   Results for the year ended 31 March 2026

   Results for the year ended 31 March 2026

   RNS 9668984 ↗
8. 02 Jul 26
   EU launch of ECOVAXXIN® MS

   ECO Animal Health Group plc (AIM: EAH), a leading global animal health company marketing and developing branded veterinary products to improve livestock productivity and welfare, announces the commercial launch of ECOVAXXIN® MS, its poultry vaccine against...

   RNS 9648461 ↗
9. 04 Jun 26
   Renewal of revolving credit facility

   ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that it has renewed its committed revolving credit facility ("RCF")...

   RNS 9600714 ↗
10. 14 Apr 26
    Appointment of Head of Business Development

    Dr Andrew Winder to identify strategic growth opportunities for ECO's R&D pipeline

    RNS 9517980 ↗
11. 31 Mar 26
    Directorate Change

    ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that Frank Armstrong has informed the Board of his intention to step...

    RNS 9499222 ↗
12. 19 Mar 26
    Full Year Trading Update

    Continued strong momentum in H2 with improved margins outperforming market expectations

    RNS 9481434 ↗
13. 11 Mar 26
    ECOVAXXIN® MG favourable USDA safety assessment

    Assessment represents a significant milestone towards US marketing authorisation

    RNS 9468253 ↗
14. 26 Feb 26
    EU launch plans for ECOVAXXIN® MS

    ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, provides an update on its commercial launch strategy for ECOVAXXIN® MS, its...

    RNS 9447703 ↗
15. 22 Dec 25
    ECOVAXXIN® MS EU marketing authorisation granted

    ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that the European Commission has adopted a decision granting EU...

    RNS 9311376 ↗
16. 18 Dec 25
    Exercise of Share Options by Director

    ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that Christopher Wilks, Chief Financial Officer, has exercised 4,309...

    RNS 9305027 ↗
17. 04 Dec 25
    Director/PDMR Shareholding Director buys

    ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that on 04 December 2025 David Hallas, Chief Executive Officer,...

    RNS 9276538 ↗
18. 01 Dec 25
    Results for the six months ended 30 September 2025

    Results for the six months ended 30 September 2025

    RNS 9265975 ↗
19. 10 Nov 25
    EMA Positive Opinion Received for ECOVAXXIN® MS

    EMA Positive Opinion Received for ECOVAXXIN® MS poultry vaccine

    RNS 9222263 ↗

Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.